SCHEMBL9425614

SCHEMBL9425614

CCCCCC(CC)CC(C)C=C=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 4/20 0.34
CYP3A4 P08684 3/20 0.34
ADH1B P00325 1/20 0.34
ADH1C P00326 1/20 0.34
ADH1A P07327 1/20 0.34
ADH4 P08319 1/20 0.34
ADH7 P40394 1/20 0.34
CA2 P00918 2/20 0.33
OPRM1 P35372 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CA1 P00915 2/20 0.32
PRSS1 P07477 1/20 0.32
PRSS2 P07478 1/20 0.32
PRSS3 P35030 1/20 0.32
MAPT P10636 2/20 0.32
TP53 P04637 1/20 0.32
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30292199 0.81 OPRM1 (0.41) ADH1BADH1CADH1AADH4ADH7
SCHEMBL11787606 0.79 ADH1B (0.44) LMNAADH1BADH1CADH1AADH4
SCHEMBL2638551 0.79 ADH1B (0.44) LMNAADH1BADH1CADH1AADH4
SCHEMBL11789799 0.79 ADH1B (0.44) LMNAADH1BADH1CADH1AADH4
SCHEMBL27967436 0.79 ADH1B (0.44) LMNAADH1BADH1CADH1AADH4
SCHEMBL22032449 0.78 ADH1B (0.44) ALDH1A1TDP1LMNATSHRCYP3A4
SCHEMBL11788862 0.74
SCHEMBL4274217 0.73 ALDH1A1 (0.52) ALDH1A1TDP1LMNATSHRCYP3A4
SCHEMBL21142990 0.73 ALDH1A1 (0.48) ALDH1A1TDP1TSHRCYP3A4ADH1B
SCHEMBL9204512 0.72 ALDH1A1 (0.46) ALDH1A1TDP1LMNATSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US claimed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed